A medication used for treating leukemia is showing promise in reducing the effects of Alzheimer's disease.
According to a small clinical study, Nilotinib is safe and has few side effects when used at low doses.
Nearly 6 million Americans suffer from Alzheimer's disease, which is a form of dementia.
While no cure exists, drug therapy may slow disease progression in some people.
According to UPI, Nilotinib was approved by the U.S.